Key factors for successful cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat diffuse malignant peritoneal mesothelioma: results from specialized peritoneal cancer center in China.

Su, Yan-Dong; Yang, Zhi-Ran; Li, Xin-Bao; Yu, Yang; Du, Xue-Mei; Li, Yan

Su, Yan-Dong; Yang, Zhi-Ran; Li, Xin-Bao; Yu, Yang; Du, Xue-Mei; Li, Yan.

Affiliation

Su YD; Capital Medical University Affiliated Beijing Shijitan Hospital, Beijing, China.
Yang ZR; Capital Medical University Affiliated Beijing Shijitan Hospital, Beijing, China.
Li XB; Capital Medical University Affiliated Beijing Shijitan Hospital, Beijing, China.
Yu Y; Beijing Shijitan Hospital, Beijing, China.
Du XM; Capital Medical University Affiliated Beijing Shijitan Hospital, Beijing, China.
Li Y; Capital Medical University Affiliated Beijing Shijitan Hospital, Beijing, China.

Int J Hyperthermia ; 39(1): 706-712, 2022.

Article in En | MEDLINE | ID: mdl-35485308

Subject(s)

Hyperthermia, Induced; Mesothelioma, Malignant; Mesothelioma; Peritoneal Neoplasms; Vascular Neoplasms; China; Cytoreduction Surgical Procedures/methods; Humans; Hyperthermia, Induced/methods; Hyperthermic Intraperitoneal Chemotherapy; Ki-67 Antigen; Mesothelioma/drug therapy; Mesothelioma/surgery; Peritoneal Neoplasms/drug therapy; Peritoneal Neoplasms/surgery; Retrospective Studies; Vascular Neoplasms/drug therapy

Key words

Cytoreductive surgery; diffuse malignant peritoneal mesothelioma; efficacy; hyperthermic intraperitoneal chemotherapy; safety

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Peritoneal Neoplasms / Vascular Neoplasms / Mesothelioma, Malignant / Hyperthermia, Induced / Mesothelioma Type of study: Observational_studies / Prognostic_studies Country/Region as subject: Asia Language: En Journal: Int J Hyperthermia Year: 2022 Type: Article Affiliation country: China

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google